Christophe Allais

10PUBLICATIONS
43CO-AUTHORS
F-block chemistryCheminformatics and quantitative structure-activity relationshipsOrganometallic chemistryWastewater treatment processesMicrotechnology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease.

Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton

|Feb 04, 2025
Palladium-Catalyzed Enantioselective Stereodivergent Desymmetrization of Cyclic 1,4-Allyldiboronates.

Hao Liang, Lorenzo D Battistoni, Sergei Tcyrulnikov

|Aug 08, 2023
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19.

Christophe Allais, David Bernhardson, Adam R Brown

|May 30, 2023
Development of the Commercial Manufacturing Process for Nirmatrelvir in 17 Months.

Christophe Allais, Christina G Connor, Nga M Do

|Apr 06, 2023
Desymmetrization of Vicinal Bis(boronic) Esters by Enantioselective Suzuki-Miyaura Cross-Coupling Reaction.

Mingkai Zhang, Paul S Lee, Christophe Allais

Pageof 2